Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Lanillos

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Cancer|July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinomaJuan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
Cancer Communications (London, England)|May 4, 2023
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodelingSara Mellid, Fernando García, Luis Javier Leandro-García, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor PrognosisAlfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Theranostics|August 15, 2019
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paragangliomaBruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Cancer|July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinomaJuan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
Cancer Communications (London, England)|May 4, 2023
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodelingSara Mellid, Fernando García, Luis Javier Leandro-García, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor PrognosisAlfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Theranostics|August 15, 2019
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paragangliomaBruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Pageof 2